FCS leaders present at NCODA 2023 Fall Summit
FCS Participating in Global Efforts To Enhance Oncology Care Through Medically Integrated Practices
FCS Leaders Sharing Insights at NCODA International Summit
Fort Myers, Fla., October 25, 2023 – Pharmacy experts and leaders from Florida Cancer Specialists & Research Institute, LLC (FCS) are contributing to improving cancer care globally as they join fellow oncology professionals for the NCODA 2023 International Fall Summit in Orlando this week. The multi-day gathering will focus on supporting and enhancing medically-integrated oncology practices to improve care for patients worldwide.
“Across our practice we have embraced a holistic approach to patient care, which has proven essential to achieving optimal outcomes for our patients, said FCS Chief Executive Officer Nathan H. Walcker. “This opportunity to share and learn alongside our colleagues will enable us, collectively, to further enhance patient experiences worldwide.”
Several discussions will feature leaders from Rx To Go, the in-house medically integrated pharmacy of FCS that works exclusively with the statewide practice to provide an advanced level of personalized assistance and disease management to patients.
FCS Director of Pharmacy Clinical Services, Rx To Go, Natasha Khrystolubova, RPh, Pharm, BCOP, who was named earlier this year to serve on NCODA’s inaugural International Executive Council alongside global pharmacy leaders, will participate in interviewing future pharmacy residents.
Natalie Kaufman, PharmD, the first participant in the FCS Medically Integrated Oncology Pharmacy (MIOP) Resident Program accredited through NCODA, will share insights gained from working daily with the FCS Rx To Go and Pharmacy Operations teams in a discussion of “Your Path to Post-grad-Residency and Fellowship.” Launched in July 2023, the program provides a pathway to ensure that recent graduates have a successful transition into pharmacy oncology.
Serving as presenters and panelists during interactive workshops and discussions at the NCODA 2023 International Fall Summit are:
- Paul Chadwick, FCS Chief Procurement Officer – NCODA’s Non-Profit Partner Update & Donor Story: Be the Match
- Kristen Boykin, PharmD, BCPS, BCOP, FCS Director of Pharmacy Operations and Chris Elder, PharmD, BCOP, FCS Associate Director of Pharmacy Clinical Services – Drug Shortages
- Eric Gardner, PharmD, RPH, FCS Director of Dispensing Operations — Challenges Practices Face with Financial Assistance and Alternative Funding Programs
- Dawn Landolph, FCS Associate Director of Pharmacy Nursing Services -Treatment Support Kits and Putting PQIs Into Action within Practices
- Jen Bradley, FCS Director of Corporate Communications, and Kat Wade, FCS Director of Marketing – Brand Reputation and Crisis Communication in Oncology Practice
Lucio N. Gordan, MD, FCS President & Managing Physician, said, “Through their experiences with the many facets of cancer care delivery, our team is well-equipped to help establish quality standards and best practices that ensure every patients receives the maximum benefit from their cancer treatment.”
FCS physicians, clinicians, pharmacists and leaders maintain active participation with NCODA through the following committees:
- Lucio N. Gordan, MD, FCS President & Managing Physician – Executive Accreditation Council
- Kara Sammons, MSPharmReg, CPhT, FCS Director of Quality and Compliance, Rx To Go – Co-Chair Accreditation Working Group
- Lauren Trisler, PharmD, FCS Clinical Oncology Pharmacist – Positive Quality Intervention (PQI) Committee, IV Chemotherapy Education (IVE) Committee
- Kristen Boykin, PharmD, BCPS, BCOP, FCS Director of Pharmacy Operations – IV Chemotherapy Education (IVE) Committee
- Jeanine Ewing, PharmD, BCOP, FCS Clinical Oncology Pharmacist – IV Chemotherapy Education (IVE) Committee
- Austin Cox, PharmD, FCS Senior Director of Trade Relations, Rx To Go – Chair, Treatment Support Kit Committee
Rx To Go is accredited by URAC for Specialty Pharmacy, Accreditation Commission for Health Care (ACHC) with Oncology Distinction, and dually accredited by the National Association of Boards of Pharmacy® (NABP®) for specialty pharmacy and digital pharmacy practice.
NCODA is a globally recognized not-for-profit organization dedicated to building a patient-centered, medically integrated community of health care providers whose focus is to innovate the continuity of cancer care so that every patient receives the maximum benefit from their cancer treatment.
comments for this post are closed
Comments